Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2016

01-05-2016 | Head and Neck Oncology

Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

Authors: Evan A. Tseros, MBBS, BMSc, MSurg, Val Gebski, BA, MStat, FRANZCR (Hon), Gary J. Morgan, MBBS, BDS, FRACDS, FRACS, FACS, Michael J. Veness, MBBS, MD (UNSW), MD (USyd), MMed, FRANZCR

Published in: Annals of Surgical Oncology | Issue 5/2016

Login to get access

Abstract

Background

The prognostic variables in patients with metastatic cutaneous nodal squamous cell carcinoma (SCC) are well documented; however, the relationship between lymph node ratio (LNR) and outcome is not well researched. LNR represents the ratio of positive lymph nodes to total excised lymph nodes. We analyzed the correlation between LNR and outcome in patients who have undergone surgery for metastatic cutaneous nodal SCC of the head and neck.

Methods

Analysis was performed on retrospectively collected data, identifying patients who underwent surgery at Westmead Hospital, Sydney. Pathology reports were reviewed to ascertain LNR. A log-rank test identified a specific LNR value to compare time to disease progression (TTDP) and overall survival (OS). Multivariate proportional hazard regression models were used to review outcome.

Results

In total, 193 males and 45 females with a median of age 68 years were identified, with a mean recorded LNR of 0.15. On multivariate analysis, an LNR cutpoint of 0.21 was a significant predictor of decreased TTDP [hazard ratio (HR) 2.34, 95 % confidence interval (CI) 4.40–0.49; p = 0.009] and OS (HR 2.75, 95 % CI 1.57–4.82; p < 0.001). Forty-nine of 238 patients (21 %) developed recurrence, with most recurrences being regional (29 of 49; 59 %). A total of 17 % of patients with an LNR ≤0.21 recurred compared with 40 % for patients with an LNR >0.21.

Conclusions

LNR is potentially an independent predictor of outcome in patients with metastatic cutaneous nodal SCC. The clinical relevance of this finding requires further validation.
Literature
1.
go back to reference Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.CrossRefPubMed Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.CrossRefPubMed
2.
go back to reference Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197:565–8.CrossRefPubMed Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197:565–8.CrossRefPubMed
3.
go back to reference Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 patients treated with metastatic nodal disease. Cancer. 2006;106:2389–96.CrossRefPubMed Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 patients treated with metastatic nodal disease. Cancer. 2006;106:2389–96.CrossRefPubMed
4.
go back to reference Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870–5.CrossRefPubMed Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870–5.CrossRefPubMed
5.
go back to reference Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68:957–66.CrossRefPubMed Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68:957–66.CrossRefPubMed
6.
go back to reference Oddone N, Morgan G, Palme C, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.CrossRefPubMed Oddone N, Morgan G, Palme C, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.CrossRefPubMed
7.
go back to reference Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319–26.CrossRefPubMed Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319–26.CrossRefPubMed
8.
go back to reference Duraker N, Bati B, Caynak ZC, Demir D. Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2151 patients. World J Surg. 2013;37:1241–8.CrossRefPubMed Duraker N, Bati B, Caynak ZC, Demir D. Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2151 patients. World J Surg. 2013;37:1241–8.CrossRefPubMed
9.
go back to reference Prabhu RS, Hanasoge S, Magliocca KR, et al. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015;37:777–82.CrossRefPubMed Prabhu RS, Hanasoge S, Magliocca KR, et al. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck. 2015;37:777–82.CrossRefPubMed
10.
go back to reference Kunzel J, Psychogios G, Mantsopoulos K, Grundtner P, Waldfahrer F, Iro H. Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2014;271:1171–80.CrossRefPubMed Kunzel J, Psychogios G, Mantsopoulos K, Grundtner P, Waldfahrer F, Iro H. Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2014;271:1171–80.CrossRefPubMed
11.
go back to reference Amit M, Yen TC, Liao CT, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. 2013;119:4242–8.CrossRefPubMed Amit M, Yen TC, Liao CT, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. 2013;119:4242–8.CrossRefPubMed
12.
go back to reference Mizrachi A, Hadar T, Rabinovics N, et al. Prognostic significance of nodal ratio in cutaneous squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2013;270:647–53.CrossRefPubMed Mizrachi A, Hadar T, Rabinovics N, et al. Prognostic significance of nodal ratio in cutaneous squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2013;270:647–53.CrossRefPubMed
13.
go back to reference Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829–35.CrossRefPubMed Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829–35.CrossRefPubMed
14.
go back to reference Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2012;34:1524–8.CrossRefPubMed Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2012;34:1524–8.CrossRefPubMed
15.
go back to reference Forest VI, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of two Australian cancer centres. Cancer. 2010;116:1298–1304.CrossRefPubMed Forest VI, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of two Australian cancer centres. Cancer. 2010;116:1298–1304.CrossRefPubMed
16.
go back to reference Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous SCC of the head and neck based on a multicentre study of treatment outcomes. Cancer. 2006;106:1078–83.CrossRefPubMed Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous SCC of the head and neck based on a multicentre study of treatment outcomes. Cancer. 2006;106:1078–83.CrossRefPubMed
17.
go back to reference Aurello P, Catracchia V, Petrucciani N, et al. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes. Am Surg. 2013;79:483–91.PubMed Aurello P, Catracchia V, Petrucciani N, et al. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes. Am Surg. 2013;79:483–91.PubMed
18.
go back to reference Clark JR, Rumcheva P, Veness MJ. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck. Ann Surg Oncol. 2012;19:4252–8.CrossRefPubMed Clark JR, Rumcheva P, Veness MJ. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck. Ann Surg Oncol. 2012;19:4252–8.CrossRefPubMed
19.
go back to reference Brunner M, Ng BC, Veness MJ, Clark JR. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer. Laryngoscope. 2014;124:1598–602.CrossRefPubMed Brunner M, Ng BC, Veness MJ, Clark JR. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer. Laryngoscope. 2014;124:1598–602.CrossRefPubMed
20.
go back to reference Ebrahimi A, Clark JR, Amit M, et al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21:3049–55.CrossRefPubMed Ebrahimi A, Clark JR, Amit M, et al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21:3049–55.CrossRefPubMed
21.
go back to reference Wang J, Palme C, Wang A, Morgan G, Gebski V, Veness M. In patients with metastatic cutaneous SCC to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol. 2013;127 Supp 1:S2–7.CrossRefPubMed Wang J, Palme C, Wang A, Morgan G, Gebski V, Veness M. In patients with metastatic cutaneous SCC to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol. 2013;127 Supp 1:S2–7.CrossRefPubMed
22.
go back to reference Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.CrossRefPubMed Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.CrossRefPubMed
Metadata
Title
Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck
Authors
Evan A. Tseros, MBBS, BMSc, MSurg
Val Gebski, BA, MStat, FRANZCR (Hon)
Gary J. Morgan, MBBS, BDS, FRACDS, FRACS, FACS
Michael J. Veness, MBBS, MD (UNSW), MD (USyd), MMed, FRANZCR
Publication date
01-05-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 5/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5070-6

Other articles of this Issue 5/2016

Annals of Surgical Oncology 5/2016 Go to the issue

Regional Therapies for Advanced Malignancies

Regional Therapies for Advanced Cancer: Update for 2016